Clinical Trials Sponsored by Laboratorios Thea, Spain

Total 164 results

Laboratorios Thea, Spain

Recruiting

Efficacy and Safety of Topical Hydrocortisone on Signs and Symptoms of Dry Eye Associated to Meibomian Gland Dysfunction

Dry Eye | Meibomian Gland Dysfunction

Spain
Laboratorios Thea, Spain
Crossdata

Completed

Impact of Tear Substitute Use on Dry Eye in Gamers. (HYAGAME)

Evaporative Dry Eye

Spain
Laboratorios Thea, Spain
Alpha Bioresearch S.L.; Investigación Estadística

Completed

Study of Nutritional Supplementation in Patients With Unilateral Wet AMD

Wet Macular Degeneration

Spain, Portugal
Laboratorios Ordesa
Ministerio de Ciencia e Innovación, Spain

Unknown

Whole Grain, Gluten-containing Cereal and PROBIOtics to Evaluate Digestive TOLERAance and Immuno-inflammatory Response (PROBIOTOLERA)

Gastrointestinal Disorder | Immunologic Diseases in Children

Spain
Prometheus Laboratories
Nestlé Health Science Spain; Nestec Ltd.

Terminated

Efficacy of CROWN in Repair and Maintenance of the Intestinal Mucosa in Patients With CD Receiving Anti-TNF Therapy (PIONEER-CD)

Crohn's Disease

United States
Prometheus Laboratories
Syneos Health; Nestlé Health Science Spain

Terminated

A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC) (PROTECT-3)

Ulcerative Colitis

United States
Laboratoires Thea

Not yet recruiting

Comparison of the Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.

Dry Eye Syndrome
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients

Ocular Hypertension | Glaucoma

United States, Colombia
Laboratoires Thea

Active, not recruiting

Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.

Ocular Hypertension | Glaucoma

United States
Laboratoires Thea

Completed

Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension

Primary Open Angle Glaucoma
Laboratoires Thea

Completed

Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma (CONDORE)

Glaucoma

France
Laboratoires Thea

Completed

Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients. (T1030)

Glaucoma

France
Laboratoires Thea

Completed

Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome

Dry Eye Syndromes

France
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients

Glaucoma

France
Laboratoires Thea

Completed

Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis

Conjunctivitis, Bacterial
Laboratoires Thea

Completed

Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers

Eye Infections, Bacterial

France
Laboratoires Thea

Completed

Efficacy of T2259 in DED

Dry Eye Syndromes

France
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.

Ocular Hypertension Glaucoma

Bulgaria
Laboratoires Thea

Completed

Clinical Investigation to Evaluate the Tolerance of T10070 on Healthy Volunteers

Healthy Volunteers

Poland
Laboratoires Thea

Completed

Efficacy, Safety of T2769 in Dry Eye Disease

Dry Eye Syndrome

Tunisia
Laboratoires Thea

Completed

Gastrointestinal Tolerance Assessment of T2309 (GATA)

Healthy Adult Subjects

France
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer

Keratitis | Corneal Ulcer

France
Laboratoires Thea

Completed

Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis

Seasonal Allergic Conjunctivitis

France
Laboratoires Thea

Completed

Warming Efficiency of Warm Compresses Versus BLEPHASTEAM® in Eyelid Therapy

Eyelid Diseases

United Kingdom
Laboratoires Thea

Completed

Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis

Keratoconjunctivitis, Vernal
Laboratoires Thea

Completed

Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers

Eye Infections, Bacterial
Laboratoires Thea

Completed

Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma

Trachoma
Laboratoires Thea

Not yet recruiting

Comparison of the Performance and Safety of T2769 Versus Vismed® Multi in the Treatment of Moderate to Severe Dry Eye Syndrome

Dry Eye
Laboratoires Thea

Completed

Performance and Safety Assessment of T2769 in Contact Lens Wearers With Dry Eye Symptoms.

Dry Eye

Bulgaria
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients

Ocular Hypertension | Glaucoma

Estonia
Laboratoires Thea

Completed

Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers

Healthy Volunteers

United States
Laboratoires Thea

Completed

Macula Evolution in Patients With AMD Taking Oral Food Supplementation

Age Related Macular Degeneration

France
Laboratoires Thea

Completed

Efficacy and Tolerability of Blephademodex Wipes

Demodex Blepharitis

Germany
Laboratoires Thea

Completed

Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose

Primary Open Angle Glaucoma | Ocular Hypertension

France
Laboratoires Thea

Completed

Performance and Safety Assessment of T4020 in Managing Corneal Epithelial Defect Following Epi-off Accelerated Crosslinking

Keratoconus

Turkey, Bulgaria, France, Spain
Laboratoires Thea

Completed

Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome

Dry Eye Syndrome

France
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients

Ocular Hypertension | Open Angle Glaucoma

France
Laboratoires Thea

Terminated

Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome

Dry Eye Syndrome

France
Laboratoires Thea

Completed

Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery

Cataract

France
Laboratoires Thea

Completed

Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.

Purulent Bacterial Conjunctivitis

France
Laboratoires Thea

Completed

Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases (ESPOIR Ext)

Eyelid Diseases

France
Laboratoires Thea

Completed

Clinical Safety Study on an Eyelid Warming Device to Evaluate the Eyelid and Cornea Temperature in Healthy Volunteers

Eyelid Diseases

United Kingdom
Laboratoires Thea

Completed

Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases (ESPOIR)

Eyelid Diseases

France
Laboratoires Thea

Completed

Efficacy and Safety of GV 550 in Acute Adenovirus Keratoconjunctivitis

Acute Adenoviral Keratoconjunctivitis

France
Laboratoires Thea

Completed

Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome

Dry Eye Syndromes
Laboratoires Thea

Completed

Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers

Eye Infections, Bacterial
Laboratoires Thea

Completed

Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers

Eye Infections, Bacterial
Laboratoires Thea

Completed

Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers

Eye Infections, Bacterial
Pain Management Center of Paducah
Millennium Laboratories

Completed

Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients

Chronic Pain
Laboratorio Elea Phoenix S.A.
Ministerio de Ciencia e Innovación, Spain

Completed

Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides

Glioma | Neuroblastoma | Retinoblastoma | Wilm's Tumor | Ewing's Sarcoma

Argentina

3

Subscribe